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Although the importance ofaeroallergens as
triggers ofasthma has been known for many
years, particularly among asthmatics with
demonstrable allergy (1), there is alackofspe-
cific information on the relationship between
the level ofexposure to specific aeroallergens
and daily asthma status. However, there is a
relative abundance of literature concerning
the inflammatory responses to respiratory
allergens among allergic asthmatics and the
importance ofanti-inflammatory therapy for
the treatment ofallergic asthma (2). The pre-
sent study focuses on the impact of fungal
spores on acute asthma severity, a topic that
has not been well investigated. Several pub-
lished studies addressing this issue involving
individual asthmatics have not utilized
time-series analytic techniques to detect acute
exposure-response relationships (3-5); other
studies have involved correlations between
aggregated exposure and response data (6-9).
Additionally, more research has been called
for regarding the synergistic or antagonistic
effects on asthma status caused by different
ambient airborne contaminants including
interactions between airpollutants andaeroal-
lergens (10Q.
The present studywas designed to inves-
tigate the potential interactive and indepen-
dent effects of ozone (03) and outdoor
aeroallergens (pollens and molds) on daily
asthma severity. This was carried out using
the panel study design, which is character-
izedbylongitudinal analyses ofdailydata for
a panel ofasthmatics, with each subject act-
ingas his orherown control. This studywas
conducted in the small Southern California
community ofAlpine, California, over an 8-
week period from 9 May through 3 July
1994. The time period was selected to maxi-
mize both 03 and fungal spore exposures,
and followed the peak spring pollen season
forthe area. This studyrepresents thesecond
in a series ofepidemilogic studies utilizing
personal passive 03 exposures. The first
study found that 12 asthmatic children fol-
lowed daily for 6 weeks showed notably
stronger adverse effects from personal 03
than from outdoor stationary site 03 and
found that outdoor airborne fungal spores
adversely effected asthma symptom levels
and as-needed bronchodilator use (11). In a
recently published 03 modeling study, Liu
et al. (12) utilized personal 03 data from the
panel of this paper and an additional panel
from the fall of 1994 in Alpine; Liu et al.
describe prediction models and factors that
determinepersonal ozone exposure levels.
Materials and Methods
Studypopulation and allergy testing. The
community targeted by this study was cho-
sen in order to maximize the ability to iso-
late the independent effect of0 from par-
ticulate air pollutants with which 03 is
commonly found to be highly intercorrelat-
ed. It is a semirural inland community of
Southern California located around the
small town ofAlpine, whose residents live
at or above the base of the air inversion
zone (1,200 feet in elevation). It has had a
permanent governmental air pollution
monitoring site since 1981, with data show-
ing high levels of transported and locally
generated ozone but low levels of particu-
late air pollution relative to more urbanized
regions ofthe United States (13).
The study protocols were approved by
the institutional review boards ofSan Diego
State University and the Southern
California Permanente Medical Group.
Informed written consent was obtained
from all subjects and one of their legal
guardians ifthey were under the age of 18
years. Recruitment ofsubjects was done by
advertisements and through four schools in
the Alpine area in addition to referrals from
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the Kaiser Permanente Health Plan, Inc.,
Southern California Region, San Diego
Area, Department of Allergy. Eligibility
criteria ofthe study included 1) physician-
diagnosed asthma with a minimum history
of 1 year; 2) asthma exacerbations during
several weeks of the warm seasons (March
through October) requiring the use ofpre-
scribed asthma medications; 3) ages
between 9 and 49 years; 4) a home and
school or work address in the Alpine area;
and 5) absence of patient/parental or
indoor household smoking. After excluding
two noncompliant subjects, the study pop-
ulation included 22 symptomatic asthmat-
ics, 9 adults ages 24-46 years and 13 chil-
dren ages 9-14 years.
Classification of allergy among subjects
was based on the presence orabsence ofposi-
tive allergen reactivity as assessed using skin
prick (epicutaneous) tests (SPT) (Bayer
Corp., Allergy Products, Spokane, WA) for
various pollens or molds common to the
study area (14). Positive SPT reactivity was
defined as a skin wheal greater than 3 mm or
with a diameter greater than 50% ofa hista-
mine dihydrochloride control while in the
presence of a negative saline control. The
SPTs for locally relevant pollens consisted of
standardized allergen extracts of nine trees,
Bermuda grass, one grass mix, and two weed
mixes. There were five SPTs for fungal spore
taxa: Alternaria alternata (extract labeled
Alternaria tenuis), Cladosporium cladospori-
odes (extract labeled Hormodendrum cladospo-
riodes), Helminthosporium interseminatum,
Aspergillusspecies mix (A.fumigatus, A. terreus,
A. niger, A. nidulans), and Penicillium species
mix (P. digitatum, P. expansum, P.glaucum, P.
roseum, P. notatum). Subjects were also skin
tested for house dust mites [Dernatophagoides
farinae(Derf) and D.pteronyssinus(Derp)].
Outcomes. Within 2 weeks prior to the
start of the study, participants were
instructed on study procedures and admin-
istered a background interview. Subjects
were trained and then tested on the proper
use of a peak flow meter (Assess,
Healthscan Products, Inc., Cedar Grove,
NJ). After the start ofthe study, weekly fol-
low-ups at the subject's homes were done
to collect personal 0 passive samplers, to
clarify the accuracy ofdiary response infor-
mation, and to discuss any problems with
the study procedures. Daily diary responses
were given concerning asthma symptom
severity, and three morning and three
evening peak expiratory flow rate maneu-
vers (PEFR) were recorded. Asthma symp-
toms (cough, wheeze, sputum production,
shortness of breath, and chest tightness)
were rated by the subjects in terms oftheir
combined severity on a scale from 0 to 5.
The six levels ofasthma severity were classi-
fied as 0, no asthma symptoms present; 1,
asthma symptoms present but caused no
discomfort; 2, asthma symptoms caused
discomfort but did not interfere with daily
activities or sleep; 3, asthma symptoms
interfered somewhat with daily activities or
sleep; 4, asthma symptoms interfered with
most activities and may have required that
the participants stay home in bed, return
home early from school or work, or call a
doctor or nurse for advice; 5, asthma symp-
toms required either going to a hospital,
emergency room, or outpatient clinic.
Subjects were instructed to record PEFR
measurements prior to using their inhalers.
The highest of the three PEFR maneuvers
was retained for the analysis. Peak flows
were invalidated if the same value was
recorded for the three successive maneuvers
or if they did less than three maneuvers.
Data were checked for repeated entries
from day to day ofthe same PEFR level as
an indication that maneuvers may not have
been performed. Weekly home visits were
used to check the performance of PEFR
maneuvers in the presence of potentially
invalid entries for the prior week. The
other main outcome recorded by the sub-
jects at the end of each day included the
number of P-adrenergic agonist inhaler
puffs used on an as-needed basis in the past
24 hr. The inhaler use variable is intended
to reflect the level of daily asthma severity
among subjects using this approach to ther-
apy, thereby complementing the symptom
variable. The presence or absence of upper
or lower respiratory tract infections was
also recorded by subjects.
Environmental variables. Twenty-four
hour samples ofairborne particulate matter
of aerodynamic diameter <10 ism (PM10)
were measured with a tapered-element
oscillating microbalance (TEOM) (15)
located centrally at a monitoring station in
Alpine and operated by the San Diego Air
Pollution Control District (SDAPCD site).
Sampling, analysis, and data processing pro-
tocols were carried out as part ofthe ongo-
ing project (Epidemiological Investigation
to Identify Chronic Health Effects of
Ambient Air Pollution in Southern
California) conducted at the University of
Southern California (California Air
Resources Board Project No. A033-186)
(13). The PMIO data was collected and
made available for this study by Sonoma
Technology Inc., Santa Rosa, CA.
Personal 03 exposures were measured
using the Harvard personal passive sam-
pler, which was worn daily by each subject
over a 12-hr period, approximately
between the hours of 8 A.M. and 8 P.M.
This time period is relevant for outdoor
exposures to peak 03 levels. The personal
03 sampler is a small device (2 cm diame-
ter by 3 cm in length), which is clipped to
the subject's clothes at chest level. Filters
are coated with a potassium carbonate and
sodium nitrite solution. Nitrite ion is oxi-
dized by 03 to nitrate ion (NO3) (16).
Ozone concentrations are determined by
the amount of nitrate measured by ion
chromatography. Comparisons of ozone
concentrations between a standard contin-
uous monitor and the passive sampler
yielded excellent agreement (16); however,
differences due to face velocity effects and
03 depletion at body surfaces were found
(17,18). The sampling methodology and
validation of these samplers is fully
described elsewhere (16-18). Continuous
monitoring ofoutdoor ozone was conduct-
ed using UV photometry at the SDAPCD
site. Weather variables measured at the
SDAPCD site included hourly temperature
and relative humidity.
Measurements of aeroallergens were
made using the Burkard 7-day recordingvol-
umetric pollen and fungal spore collector
with a sample flow rate of 10 1/min (Burkard
Manufacturing Co., Rickmansworth
Hertfordshire, England). Placement of the
pollen and fungal spore sampler at the
SDAPCD site ensured no nearby upwind
obstructions and was 4 m above the ground.
To prepare the sampler forpollen and fungal
spore collection, Melenix tape (Burkard
Manufacturing Co.) was placed on the
mounted drum of the sampler and coated
with silicone solution evenly applied with an
artist's brush. After 7 days of continuous
sample collection, the tapewas cut into seven
24-hour segments from 8 A.M. to 8 A.M. and
mounted onto microscope slides. The vari-
ous fungal spores and pollen grains were
then counted and identified using a com-
pound microscope at 50Ox and 1000x. The
pollen and fungal spore counts were then
converted into spores per cubic meter ofair
foreach 24-hourperiod.
Analytic variables for the total fungal
spore and total pollen concentrations were
derived by summing the dailyconcentrations
of all identified and unidentified types of
these two allergen groups. Other fungal vari-
ables were created by summing spore con-
centrations across genera related to the com-
monly assessed fungal SPTs as follows: 1) a
test fungi variable was the sum ofconcentra-
tions ofeach ofthe five fungal genera repre-
sented by the five fungal SPTs; 2) a nontest
fungi variable was the total fungal spore con-
centration minus the test fungi concentra-
tion; 3) a positive SPT fungi variable was the
sum offungal spore concentrations of those
five genera represented by the five fungal
SPTs to which a subject tested positive; and
4) a negative SPT plus nontest fungi variable
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was total fungal spore concentration minus
the positive SPT fungi concentration. The
assumption here was that a positive SPT to a
fungal extract was an indication ofallergy to
the genus, although cross-reactivity patterns
within single genera have not been fully
describedand are notlikelyto be 100%.
Analysis. The analysis began with descrip-
tive statistics, which included time plots for
the examination of possible trends in the
data. Exposure correlation matrices were con-
structed to assess the amount ofintercorrela-
tion that could imply potential confounding
ormulticollinearity in the regressionanalyses.
Regression analyses were based on the
general linear mixed model, which estimates
both fixed and random effects (SAS MIXED
procedure) (19) and is particularly suitable
forlongitudinal dataanalysis ofserially corre-
lated data in individuals (20). The SAS
MIXED procedure optimizes a restricted
maximum likelihood (REML) function by
using the Newton-Raphson algorithm
(19,21). Repeated daily measurements over
time in every research subject constitutes a
cluster of observations. The random effects
modeling accounts for the heterogeneity
from one such cluster of observations to
another. This approach is applicable to this
study because the periodicity of attacks and
etiology of asthma is highly heterogeneous
among asthmatics. For example, modeling
each subject as a random effect using this
procedure would accommodate the variation
in the use ofanti-inflammatory medications
that could block an asthmatics respiratory
response to an aeroallergen. This modeling is
accomplished by essentially treating the sub-
ject's cluster of observations as a sample of
intercepts and slopes (regression parameters)
from some underlying population distribu-
tion. It is conceptually a set of separate
regression models on repeated measurements
over time for each individual. Every subject
can therefore act as his or her own control.
Anthropomorphic differences such as age,
height, and gender that could potentially
lead to differences in lung function were
controlled for by estimating separate random
intercepts for each individual. This allows
the evaluation ofthe fixed effects ofinterest
(aeroallergens and pollutants). For each
modeled exposure, a common regression
slope and its standard errorwere estimated.
The mixed model is a linear model that
can account for correlated responses and the
dependence of repeated observations in a
single individual. The serial correlation must
be accounted for to prevent bias in the esti-
mation of statistical significance. The
Akaike's information criterion (AIC, REML
log likelihood-the number of covariance
parameters) (19) was used to assess the fit of
the various mixed models having the same
fixed effects, but with versus without model-
ing autocorrelation of the residual error
terms. It was consequently found that the
best models included first order autoregres-
sive parameters to control for significant
autocorrelation ofresidual errors. In addition
to examining the relationship of asthma
responses to same day exposures, levels of
environmental factors were lagged 1 day
prior to the day in which the diarywas com-
pleted and compared to response levels to
account fordelayed effects.
Although symptom scores and as-need-
ed n-agonist inhaler doses are ordinal out-
come variables with non-normal distribu-
tions, residual errors from regressions using
these ordinal variables in the models were
found to be approximately normal, as indi-
cated by normal probability plots and
means of zero. In the regression analyses,
maximum temperature and average relative
humidity were examined for confounding
and interaction, and days of the week
trends in the outcome and environmental
variables were tested to assess potential bias
in the estimation ofeffects.
The estimates of effect were rescaled to
represent the effect of a multiple unit
change in exposure in its daily concentra-
tion (e.g., change in PEFR per increase of
100 ppb 03). Standard errors ofthese esti-
mates are also given. For the individual fun-
gal types (e.g., Altemnaria), this scale reflects
the effect at the 90th percentile of the dis-
tribution for that fungal variable (i.e., the
difference between the upper decile and the
minimum concentration). This will allow a
standardized view of effects for the fungal
concentration ranges measured in this
study. These effect estimates will be referred
to in this paper as 90th percentile effects.
Since concentrations for any particular
group can be much higher in other geo-
graphic areas or during different time peri-
ods in the region ofstudy, we will also pre-
sent results for fungi as the amount of
change in the response variable per increase
of 1,000 fungal spores/m3 of air. This is
useful because it is largely unknown what
the magnitude of effects or thresholds are
for different fungal taxa, although it is
expected to vary based upon individual sen-
sitivity and fungal species (22). It should be
cautioned, however, that for some fungal
taxa with measured concentrations less than
1,000 spores/m3, this effect magnitude
would constitute an extrapolation beyond
the estimated regression slope. For the
Table 1. Characteristics of individual participants in the spring 1994Alpine Panel Study
Tested Mean
fungal spore symptom Inhaler
Subject Gender Age Medications allergiesa score ± SD puffs ± SD
Pediatric
subjects
1 Male 14 Al, Be*, Cr,Th* A, As, C, H, P, 0.22 ± 0.57 0.00 ± 0.00
2 Male 13 Al, Be A,As, C, P 1.46 ± 1.06 1.34± 0.94
3 Female 14 Al, Cr* None 1.08 ± 1.09 0.59 ± 1.04
4 Female 11 Al A,As, C, H, P 0.95± 1.35 0.69± 1.10
5 Male 11 Al, Be* A, As, H. P 0.86 ± 0.86 2.27 ± 1.98
6 Female 10 Al A,As, C, H, P 0.38 ± 0.97 0.09 ± 0.35
7 Female 13 Al, Be, A, As, C, H, P 1.10 ± 1.33 1.80 ± 3.49
8 Male 15 Al*, Be, Cr* None 1.32 ± 0.83 0.93 ± 0.81
9 Male 10 Al, Tr, Th A, As, C, H, P 0.79 ± 1.32 4.55 4.39
10 Male 13 Al A, C, H, P 1.69 ± 0.70 0.62± 1.01
11 Male 12 Al, Be* A,As, C, H, P 1.91 ± 0.86 0.09 0.36
12 Female 12 Al None 2.22 ± 0.42 1.27± 1.27
13 Female 11 Al, Cr* A 1.89 ± 0.98 7.24 2.36
Adult
subjects
14 Male 37 Al, Be None 1.09 ± 1.08 1.02 1.04
15 Female 25 Al*, Be* A 0.66 ± 0.98 0.90± 1.65
16 Female 44 Al, Be None 0.95 ± 0.92 2.50± 2.60
17 Female 47 Al, Be* None 2.02± 0.98 1.11 ± 1.47
18 Female 38 Be* A 1.48 ± 1.18 0.00± 0.00
19 Female 36 Cr,Tb A, H 1.46 ± 0.91 2.23 1.72
20 Male 38 Al, Be* A, P 2.71 ± 0.53 4.13± 1.63
21 Female 24 Al A,As, C, H, P 2.46 ± 0.59 6.77± 1.44
22 Female 33 Tb A, C, H 0.81 ± 1.33 0.30 0.73
Abbreviations: Al, albuterol; Tr, triamcinolone acetonide; Be, beclomethasone dipropionate; Cr, Cromolyn;
Th, theophyllin; Tb, terbutaline; A, Altemaria altemata; As, Aspergillus mix; C, Cladosporium cladospori-
odes-, H, Helminthosporiuminterseminatunrr, P, Penicilliummix.
*Indicates thatthe medication was prescribed for daily use, with the subjecttaking it as prescribed dur-
ing the study, in addition to as-needed J3-adrenergic agonist inhalers (Al and Tb). Albuterol was both as-
needed and prescribed dailywhere indicated by*.
aPositive fungal spore allergiestested with multitest epicutaneous punctures.
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summed fungal variables defined above,
effects are expressed as response change per
1,000 fungal spores/m3, which is within
their observed concentration range.
In addition to the mixed model analysis
of the panel data, autoregressive linear
regression analyses of each individual's
time-series data were performed to explore
the possibility that particular subjects were
responding to environmental exposures.
This was accomplished using the SAS
AUTOREG procedure (SAS Institute,
Cary, NC) to estimate the autoregressive
parameter(s) that were selected on the basis
ofcontrolling autcorrelation ofthe residual
error as described above.
Statistical significance of fixed effects
was attributed to p-values <0.05 for two-
sided t statistics. The 0.05 level of signifi-
cance was appropriately used as a test ofsig-
nificance rather than a more conservative
Bonferroni correction: p<0.051k tests, since
there is ample evidence from experimental
and nonexperimental studies that positive
associations were to be expected for air pol-
lutants and aeroallergens. Bonferroni or
other multiple testing corrections are appro-
priatewhere litde or no apriorievidence for
effects is available. Despite the expectation
of adverse effects, significance testing was
based upon a two-sided critical value. It was
also expected that the use of a single out-
door monitoring site for aeroallergen expo-
sures would lead to exposure misclassifica-
tion and inflation of variance estimates.
Therefore, models with p-values <0.1 were
indicated in tables for individual fungal
types and for autoregressive models testing
effects in individual subjects.
Results
Outcomes. The characteristics of the 22
subjects are shown in Table 1. Subjects in
this studywere using a variety ofas-needed
n-agonist inhalers and daily prescribed
medications, and 11 subjects took only as-
needed 3-agonist inhalers. Percent predict-
ed PEFR (23,24) calculated from the aver-
age evening PEFRs were below 88% for
both the pediatric and adult groups. There
was little difference overall between the
average levels of evening and morning
PEFR, with a diurnal difference of only
3% higher levels in the evening than in the
morning. Sixteen subjects were allergic to
at least one of the five fungal SPTs; of
these, all were allergic to Alternaria, and
three were only allergic to Alternaria. All
nine subjects allergic to Aspergillus were
also allergic to Penicillium, but two subjects
were allergic to Penicillium but not
Aspergillus. This is important in the analysis
of effects of these two spore types on the
asthma outcomes, including the positive
SPT variable, since Penicillium spores can-
not be distinguished from Aspergillus under
Table 2. Descriptive statistics for daily air pollution, aeroallergen, and weather measurements, 9 May-3
July 1994, Alpine area ofSan Diego County
Exposure
03 outdoor site 1-hr max(ppb)8
03 outdoor site 12-hr (ppb)b
03 personal 12-hr(ppb)c
PM1O 24-hr(pg/m3)
Temperature 1-hr maximum (0F)
Relative humidity 24-hr (%)
Total fungal spores 24-hr/m3c
Alternaria24-hr/m3
Cladosporium24-hr/m3
Helminthosporium24-hr/m3
Aspergillus and
Penicillium24-hr/m3
Coprinus24-hr/m3
Periconia24-hr/m3c
Botrytis24-hr/m3
Total ascospores 24-hr/m3c
Total basidiospores 24-hr/m3c
Hyphal fragments 24-hr/m3
Rusts 24-hr/m3
Unidentified spores 24-hr/m3
Pollen grains24-hr/m3
Number obs
56
56
1046
41
56
56
55
55
55
55
55
Mean ± SD
88 ± 25
64 ± 17
18 ± 14
26 ± 11
75 ± 11
68 ± 19
2,959 ± 1,200
99 ± 66
1,430 ± 668
21 ± 17
38 ± 47
55 36±60
54 64± 55
55 36 ± 48
53 113±93
54 94±96
55 203 ± 108
55 36±23
55 717 ±393
55 216 ± 144
Minimum/maximum 90th percentile
46/147 119
34/103 84
0/80 38
6/51 52
55/101 88
20/98 90
655/6,032 4,538
0/296 190
247/3094 2,220
0/78 49
0/204 120
0/374
0/233
0/211
0/423
7/458
21/416
0/99
56/1,832
11/611
85
127
85
232
190
352
70
1,226
410
Abbreviations: obs, observations; SD, standard deviation; PM10, particulate matter of aerodynamic diame-
ter <10 pm.
aThe stationarysite outdoormonitorwastheAlpine site operated bythe San DiegoAirPollution Control District
bLevels for the 12-hr sampling period were averaged from 8 A.M. to 8 P.M.; levels for the 24-hr sampling
period were averaged from 12 A.M. to 12 P.M. for PM10, temperature, and relative humidity and from 8 A.M.
to 8 A.M. forfungal spores and pollen grains.
cThe above statistics exclude high outliers for 12-hr personal 03 (13 obs from 90 to 176 ppb); total fungal
spores and total basidiospores (1 obs due to a gastromycete contaminant at2,741 spores/m3); Periconia (1
obs at402spores/m3); total ascospores (2 obs at677 and 881 spores/m3).
the microscope. This required that respons-
es from all 11 subjects be regressed on the
summed concentrations ofAspergillus and
Penicillium. All subjects were SPT positive
to at least one pollen extract and 16 sub-
jects were allergic to one or both dust mite
antigens (Derfand Derp).
Dailydiaries were obtained for a total of
1,218 person-days of observations from a
possible 1,250 person-days. During this 8-
week study, noncompliance with diary
completion accounted for 32 person-days.
There were 1,152 person-days of observa-
tion for asthma symptoms and 883 person-
days ofobservation for as-needed n-agonist
inhaler use. There were two subjects who
only took prescribed inhalers daily
(beclomethasone dipropionate) and did not
use as-needed ,-agonist inhalers (subjects 1
and 18, Table 1), accounting for 112 days
not induded in the analysis ofas-needed 3-
agonist inhaler use. The remaining observa-
tions unavailable for analysis were in error
or missing largely because subjects failed to
enter a zero and, instead, left the field
blank, despite repeated instructions to enter
zeros if there were no symptoms or ifthey
did not require as-needed ,B-agonist
inhalers. Subjects were not allowed to recall
events more than 1 day in the past; there-
fore, blank observations were considered
missing. There were a total of 1,114 per-
son-days ofobservation for morning PEFR
and 1,107 person-days of observation for
evening PEFR, with most ofthe remaining
missing observations (104 and 111 person-
days, respectively) for times when subjects
did not perform maneuvers or made invalid
entries. All ofthe PEFR data was invalidat-
ed for one subject who frequently did not
perform the peak flow maneuvers properly
despite retraining (subject 3, who used the
spitting technique rather than a forced expi-
ratory maneuver over several seconds).
There were no significant day-of-week
trends in any ofthe outcome variables, but
asthma symptom scores and as-needed
inhaler use were slightly lower on average
for Saturdays than for the rest of the week
(p<O.12). Inclusion ofa day-of-week indica-
tor variable in the regression models for
these variables did not confound any ofthe
associations reported below. Also, all three
of the outcomes were significantly worse
during the reported presence versus absence
ofrespiratory infections on 43 versus 1,094
person-days of observation, respectively
(p<0.02). However, none ofthe associations
reported below were confounded by the
presence ofrespiratory infections.
Correlations between the three out-
comes were tested with Spearman's rank
correlation. The correlation of PEFR to
both asthma symptom scores and as-needed
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inhaler use was near zero, but symptom
scores and as-needed inhaler use were mod-
eratelycorrelated (R= 0.55,p<O.0001).
Exposures. Out of a potential of 1,232
person-days of observation for personal 03
samples, 117 observations were not obtained
because the badge had not been worn, and
56 observations were invalidated due to
other field errors by subjects or analytical
problems. In addition, 13 personal 03 sam-
ples were more than four times the standard
deviation of the sample distribution above
the mean (.90 ppb, 12-hr average), leaving
1,046 samples for analysis (Table 2). We
believe that these high measurements repre-
sent laboratory or analytic error because they
are higher than outdoor concentrations and
they were sampled during weekdays when
subjects spent a majority oftime indoors. In
fact, after removing these in our ozone mod-
eling study noted above, the expected higher
concentrations on the weekends than on
weekdays became clearer because subjects
spent higher fractions of time outdoors on
Table 3. Correlation matrix of air pollution, aeroallergens, and weather, Alpine area of San Diego County,
9 May-3 July 1994a
Minimum
Personal Stationary Fungal. Maximum relatve
PM10 038 site 03 spores Pollen temperature humidity
PM 1.00 0.15k 0.55k 0.21 0(59t 0.66t O4A9
Personal 0 1.W 0.8 -0.07 0.23 0.08 -0.02
Stationary site 03 1.00 0.20 O.87+ 0.80 -0.74t
Fungal spores 1.00 0.24 0.18 -0.27
Pollen 1.00 0.56 -0.59t
Maximumtemperature 1.00~d ~ ...~ify q` -0.88'
rl? if!1gG!saF$Fi ss gr?: iSj gl! SS
` I P
Minimum relative humidity 10
PM10, particulate matter of aerodynamic diameter <10pm.
aSample sizes are given in parentheses; ozone (03) vaniables are 12-hr daytime exposures. Pearson's R
correlations were used except for personal 03 (Spearman s rank correlations were used because of its
markedly log-normal distribution).
*p<0.05;**p<0.01;0 tp<00010
weekends (12). The possibility of indoor
point sources for these values is remote since
none ofthe subjects were operating electro-
static air filters, and exposure to copier
machines would have to occur over long
periods oftime to account for such high lev-
els. The limit of detection (LOD), defined
as three times the standard deviation ofthe
blanks (61 unexposed samplers), was 16.7
ppb. Given that subjects spent most oftheir
time indoors during the 12-hr daytime sam-
pling period (mean duration 71%), a major-
ity (55%) of the personal 03 samples were
at or below the LOD. Therewere 53 (5.1%)
personal 03 samples that were 0 ppb. The
frequent number of low personal 03 mea-
surements is in part attributable to lower
levels of03 found indoors compared to out-
doors, as previously reported (17). However,
some of these observations may have been
due to subjects not uncapping the sampler;
but this could not be verified in the present
study. The distribution of personal 03 was
markedly log-normal (skewness 1.1), and
geometric mean (13 ppb) and standard devi-
ation (2.6 ppb) was lower than arithmetic
levels (Table 2). Consequently, a log trans-
formation was tested along with untrans-
formed data in the regression analysis of03.
In contrast, the skewness for the outdoor
12-hr mean 0 was 0.2 (Shapiro-Wilk sta-
tistic 0.95). Tge geometric mean personal
03 exposure concentration was 22% of the
arithmetic 12-hr mean 03 at the outdoor
stationary site (64 ppb). In addition, a high
Table 4. Correlation matrix offungal types, Alpine area of San Diego County, 9 May-3 July 19948
Alternaris Cladospor Helminth Asp-Pen Coprinus Pericon Botrytis Ascospore Basidio Hyphae Rut prsN
Altemnaria 1.00 O.65t O.56t 0.24 0.064 0.14 O.5lt -0.09 -0.01 O5 04" .4
if ! a (~~~~~~~~~~3j ifL".t-~~~~~~~~~~~~~~ n:~~~~ ~~~ ~~~ r;~~~~~iL iIIUJ_1 5;.f.11 ,.
C/ad 1.0 O55 029 0.34' ...0.2 0.16 0.2 O.0~ 025 .O5
4W MM 1 iw tn AP51i 1iuv Al
Asp Pen 1002 0234 0.33 0.034ff- -0`:"'.00 0.09 0.24 0.19 02
2.:5;.~~~ ~~~~~~~~s,.,.S.,......... 119 4341 (PR St~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~".....P?...
....,.... ........ .....iU ........if MI:15
Heiminth 1.00 0.16 28 0.04 0.38 -0.08 0.12 ~~~~100 O4O~ .12
...a.. .......r I...a ~ 51
...... .. 5. . ~5.iU 5 ~ jSf5 ~iif
I.... .a ~ 4 i ...........5...
5. a~~~ if CU aaif5.I.:.hii~~~~~~~~~'t .5....~~~~.........5.
El~~~ ........... ........... iffifSi S f~f M:...5 qU r 5 . .
~~ ~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ I~
.... h;E
...... .11.11.. N.
..~~~~~~~~~~~~~~~~~~~~-U.~ fi .....ii....15.......i
1 ... if
P*005o "<0.01;tp<07.001J1.`
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degree of interindividual variability in per-
sonal 03 concentrations was found, as pre-
sented in our previous paper (12).
Due to equipment malfunction, 15
days were missing for PM10 Levels of
PM1O were low as expected with the maxi-
mum 24-hr average being only 51 pg/m3
(Table 2). The distribution of PM1O was
approximately normal (skewness 0.1,
Shapiro-Wilk statistic 0.98). On 1 day (15
May) most of the Burkard tape adhesive
surface was lost.
Levels of fungi were moderately high
but pollen was low, given that the spring
pollen season in the region had nearly
ended at the beginning ofthe study (Table
2). Pollen levels were dominated by one
pollen from the native plant Adenostoma
(mean 125 grains/m3). The most common
spore was Cladosporium (mean 1,430
spores/m3). Alternaria (mean 99 spores/m3;
maximun 296 spores/m3) was only 3.3% of
the average total fungal concentration.
Concentrations of one of the SPT fungi,
Helminthosporium, was low (mean 21
spores/m3). Coprinus was one basidiospore
examined separately because it was one-
third of the total basidiospore concentra-
tion (Table 2). Three fungal taxa
(Aspergillus-Penicillium, Coprinus, and
Botrytis) showed markedly log-normal dis-
tributions because offrequent zeros or low
concentrations (skewness >1.5) and had
geometric means of 15-16 and geometric
standard deviations (SD) of 4-5. One
extreme outlier for the basidiospores of
2,818 spores/m3 (>7 times the SD and >29
times the interquartile range) was due to an
unusual peak in gastromycetes (puffballs)
of 2,741 spores/m3. Because the 90th per-
centile of gastromycetes was zero and the
nature ofpuffballs is to release large bursts
of spores, it is likely that this observation
was due to a puffball release near the
Burkard spore trap. Therefore, the observa-
tion was dropped because it was not rele-
vant to the regional analysis of health
effects. A notable effect ofthis single obser-
vation on the regression analysis is
described in Results. As compared with the
fungal types reported in Table 2, smaller
concentrations (means <20 spores/m3)
were found for numerous other fungal taxa
(Smuts, Epicoccum, Oidium, Ganoderma,
Bovista, Stemphylium, and others). They are
grouped together with the other spore
types into the nontest fungi variable.
Acorrelation matrix for the airpollutant,
summed aeroallergen, and weather variables
is presented in Table 3. There were several
modest but statistically significant correla-
tions of the air pollutants (PM1O and 03)
with the aeroallergens (total pollen and total
fungal spores), suggesting a potential for
aeroallergens to confound or modify associa-
tions between air pollutants and respiratory
health outcomes, or vice versa. This was due
in large part to shared meteorological deter-
minants with higher levels ofthese variables
during warm, dry weather, although many
fungi in the region ofstudy, particularly the
ascomycetes and basidiomycetes (14), sporu-
late during damp, cool periods when pollu-
tion levels are lower. Correlations ofthe out-
door environmental variables to personal 03
exposure measurements were low, again sug-
gesting that personal activity patterns such as
indoor residence time dominated the expo-
sureprofile (12).
The basidiomycetes and ascomycetes
were not significantly correlated with the
remaining nontest spores as a group or with
the test fungi variable (p>O.15). Table 4
shows a correlation matrix for the specific
fungal types examined, which further sup-
ports this finding. A small correlation was
found between basidiospores and ascospores
(R = 0.35) and between basidiospores and
one of the deuteromycetes, Botrytis. The
deuteromycetes (Periconia, Botrytis, and the
five test fungi) were moderately correlated
with each other in general. Two test fungi
(Alternaria and Cldsporium) were moder-
ately correlated to hyphal fragments, rusts,
and unidentified spores with the exception
of Cladosporium and rusts. Higher levels of
ascomycetes and basidiomycetes were found
during the cooler, damper period during
the first 3 weeks of the study, which con-
tributed to a lack of temporal correlation
with the other spore types, many ofwhich
like the deuteromycetes of Alternaria and
Cladosporium sporulate in response to low
humidity (25).
Regression models, symptom severity. A
major determinant of symptom severity
was maximum temperature, with hotter
temperatures being associated with lower
symptom levels (Table 5, model A; symp-
tom scores decreased by 0.2 for each 10°F
increase in temperature). Temperatures
were warm for all ofthe study period after
26 May; for the period before 26 May, 12-
hr daytime average temperatures never
Table 5. Asthma symptom severity score: selected regression models, the Alpine Asthma Panel Study,
9 May-3 July 1994
Estimated
Model Variables coefficient8± SE p-value
All subjects (n = 22)
A Maximum temperature -0.021 ± 0.003 0.00001
B Total fungal spores 0.070 ± 0.026 0.009
C Total fungal spores 0.093 ± 0.026 0.0003
Maximum temperature -0.024 ± 0.003 0.00001
D Testfungib 0.158 ± 0.042 0.0002
E Nontestfungic 0.139 ± 0.053 0.009
Subjects allergic to
fungal spores tested
(n= 16)
F Total fungal spores 0.108 ± 0.031 0.0006
G Positive SPTfungid 0.159 ± 0.062 0.01
H Negative SPT and nontestfungie 0.134 ± 0.044 0.003
Pediatric subjects
Total fungal spores 0.102 ± 0.033 0.002
(n = 13 subjects)
J Positive SPTfungi 0.134 ± 0.069 0.05
(n = 10 allergic subjects)
K Negative SPT and nontestfungi 0.107 ± 0.062 0.09
(n = 10 allergic subjects)
Adultsubjects
L Total fungal spores 0.072 ± 0.041 0.08
(n =9)
M Positive SPTfungi 0.296 ± 0.125 0.02
(n = 6 allergic subjects)
N Negative SPT and nontestfungi 0.135 ± 0.057 0.02
(n = 6 allergic subjects)
SPT, allergy skin pricktests; SE, standard error.
8Regression coefficients for fungal exposures and their standard errors are x 1,000 fungal spores per m3;
models C-N controlled for maximum temperature (OF) and involve exposures on the same day as symptom
reporting.
bFungal spore concentrations of those five genera represented by the SPTs, namely, Alternaria,
Helminthosporium, Cladosporium, Aspergillus, andPenicillium.
cTotal fungal spore concentration minus the five genera represented by SPTs.
dFungal spore concentration ofthose five genera tested to which subjects showed a positive SPT.
eTotal fungal spore concentration minus the concentrations of the five genera tested to which subjects
showed a positive SPT.
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dropped below 530F. Total fungal spore
concentrations were positively associated
with asthma symptom scores, and the mag-
nitude ofthe relationship was greater when
controlling for temperature (Table 5,
model C). The remaining models in Table
5 control for temperature. The magnitude
of the association with asthma symptoms
was similar for test fungi and nontest fungi
(Table 5, models D and E, respectively).
For an increase of 1,000 test or nontest
fungal spores/m3, asthma symptom scores
significantly increased by 0.16 and 0.14,
respectively. A time-series plot of mean
o
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symptom scores adjusted for temperature
versus test fungal spore concentration illus-
trates the relationship, but note that the
regression analysis was based upon individ-
ual time-series data and not on data aggre-
gated across subjects as shown in Figure 1.
The analysis was then restricted to the 16
subjects with apositive SPT to at least one of
the five fungal genera tested. The largest
parameter estimate was found for positive
SPT fungi, as opposed to total spore concen-
trations or to negative SPT plus nontest
fungi. However, differences were small and
the standard error ofthe estimate was larger a-S11;1EWi|llEii|2.2
O-ii 211 11: lX X S iSl | i Sli | !E*-* * Fungalspore concentration 2.0
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Figure 1. Time plot of daily mean asthma symptom scores and test fungal spore concentration: spring
1994Alpine Panel Study. Asthma symptom scores are averaged across 22 subjects and adjusted for maxi-
mum hourly temperature. Testfungal spore concentrations are in spores/m3 air and include summed con-
centrations of those five genera represented by the allergy skin prick tests, i.e., Alternaria,
Helminthosporium, Cladosporium, Aspergillus, and Penicillium.
Table 6. Evening peak expiratory flow rate (PEFR) and as-needed f-agonist inhaler use: selected regression
models,the Alpine Asthma Panel Study, 9 May-3July 1994
Model Variables Estimated coefficient SEa p-value
Peak expiratory flow rate
A Maximum temperature 0.52 ± 0.17 0.003
B Total fungal spores -2.37 ± 1.34 0.08
C Total fungal spores -3.10 ± 1.35 0.03
Maximum temperature 0.63 ± 0.18 0.0003
D Testfungib -4.33 ± 2.20 0.05
E Nontestfungic -6.17 ± 2.74 0.03
As-needed 3-agonist inhaler use
F Maximum temperature -0.010 ± 0.007 0.14
G Relative humidity 0.007 ± 0.004 0.06
H Total fungal spores 0.074 ± 0.046 0.12
Total fungal spores 0.085 ± 0.047 0.07
Relative humidity 0.008 ± 0.004 0.07
J Testfungi 0.161 ± 0.070 0.02
K Nontestfungi 0.150 ± 0.094 0.12
aRegression coefficients forfungal exposures and their standard errors (SE) are x 1,000 fungal spores/m3
and involve exposures on the same day as PEFR measurements (I/min) in 21 subjects, orthe same day for
which the number of inhaler puffs were reported in 20 subjects; regression models C-E for PEFR con-
trolled for maximum temperature (OF) and regression models I-K for inhaler use controlled for mean rela-
tive humidity (%).
bFungal spore concentrations ofthose five genera represented by the allergy skin prick tests (Altemaria,
Helminthosporium, Cladosporium, Aspergillus, and Penicillium).
cTotal fungal spore concentration minusthe five genera represented by skin pricktests.
forthe positive SPT fungi (Table 5, model G
vs. models F and H, respectively). There
were no significant effects of fungal spores
(induding total, test, and nontest fungi) on
asthma symptom scores in models induding
the six individuals with negative SPTs for the
five fungal taxa (p<0.2; models not shown).
The analysis was further subdivided into
pediatric and adult groups. Again, for both
age groups, the largest parameter estimate
was for positive SPT fungi, but higher stan-
dard errors were also found (Table 5, models
J and M). The largest parameter estimate of
any of the models for fungi in Table 5 was
for positive SPT fungi for the sixfungal aller-
gicadults (model M; asthmasymptom scores
increased 0.3/1,000 spores/m, p<0.02).
However, 95% confidence limits clearly
include the point estimates for the other
models (0.05-0.54/1000 spores/m3). In con-
trast to the model for asthma symptom
scores among all nine adults in relation to
total fungal spore levels (Table 5, model L),
symptoms among the six fungal allergic
adults were significantly associated with total
fungal spore levels (scores increased
0.14/1,000 spores/m3; p<0.02; model not
shown). Again however, 95% confidence
limits overlap considerably with other esti-
mates (0.04-0.23/1,000spores/m3).
Neither total pollen nor Adenostoma
pollen levels were associated with asthma
symptom severity. Also, personal 03, sta-
tionary site outdoor 03, and PMIO were
not associated with symptoms. Log-trans-
formed personal 03 was also not associated
with symptoms. No interaction or con-
founding between these environmental
variables and fungal spores or weather vari-
ables was found in relation to symptoms.
Regression models, peak expiratoryflow
rates. Evening PEFR, but not morning
PEFR, was inversely associated with fungal
spore concentrations. As with symptoms,
there was a major effect on evening PEFR
from maximum temperature, with hotter
temperatures being associated with higher
evening PEFR (Table 6, model A; increase
of 5.2 l/min/10°F; p<0.003). Similar to the
association between asthma symptoms and
fungi, the magnitude of the effect of total
fungal spores on PEFR was greater when
controlling for temperature, and this effect
became statistically significant (Table 6,
model C). The magnitude of the inverse
association to PEFRwas similar for both the
test fungi and nontest fungi (Table 6, mod-
els D and E, respectively). For an increase of
1,000 test or nontest fungal spores/m3,
PEFR decreased by 4.3 and 6.2 1/min,
respectively (p<0.05).
Asubsetanalysis involvingthe 16 subjects
who had at least one positive SPT to the test
fungi showed the largest effect from positive
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SPT fungi (-5.5 l/min/1,000 spores), as com-
pared with total spore concentrations
(-2.8 1/min/1,000 spores). However, these
effects were borderline statistically significant
(p<0.08). There were no significant effects of
fungal spores on PEFR in a group analysis of
the six individuals with negative SPTs for
fungi. Asubset analysis ofthe effect offungal
spore concentrations on PEFR among pedi-
atric and adult groups showed that although
nearly all parameter estimates were negative,
the only statistically significant model was for
the effect oftotal fungal spore concentrations
on pediatric subjects (-3.1 l/min/1,000
spores;p<0.05).
Similar to results for symptoms, there
were no associations ofmorning or evening
PEFR to total pollen, Adenostoma pollen,
personal 03, stationary site outdoor 03, or
PM10. No interaction or confounding
between these environmental variables and
fungal spores or weather variables was
found in relation to PEFR.
Regression models, as-needed inhaler
use. As-needed 3-agonist inhaler use varied
inversely with maximum temperature
(Table 6, model F; -0.1 puffs/10°F;p<O.14)
and positively with average relative humidi-
ty (0.07 puffs/10%; p<0.06). The magni-
tude and statistical significance ofan associ-
ation between inhaler use and total fungal
spore concentrations alone was greater
when controlling for relative humidity
(Table 6, model I vs. model H) or for tem-
perature. Inclusion of temperature in the
regression did not improve the fit of the
model as well as humidity. The magnitude
ofthe association to inhaler use was similar
for test fungi and nontest fungi, but only
the test fungi were statistically significant
(Table 6, models J and K). For an increase
of 1,000 test fungal spores/m3, inhaler use
increased by 0.16 puffs (p<0.02).
A subset analysis ofthe 16 fungal aller-
gic subjects again showed the largest effect
estimate from positive SPT fungi (0.20
puffs/1,000 spores/m3; p<0.07), although
the p-value was smaller for total spore con-
centrations (0.1 1 puffs/1,000 spores/m3;
p<O.001). Therewere no significant associa-
tions between inhaler use and fungal spores
in the six individuals with negative SPTs for
the five fungal taxa (p<0.5). The only statis-
tically significant effects on inhaler use
among adults were for positive SPT fungi
on the 6 fungal allergic adults (0.44
puffs/1,000 spores/m3; p<0.05). However,
the largest effect on inhaler use in the pedi-
atric group was for negative SPT plus non-
test fungi among the fungal allergic (0.36
puffs/1,000 spores/m3; p<0.003) as com-
pared to total spore concentrations for
either all children or fungal allergic children
(0.14 and 0.17 puffs/1,000 spores/m3,
respectively; p<0.02). The lower 95% confi-
dence limit for negative SPT plus nontest
fungi just includes these point estimates for
total fungi (0.12-0.59/1,000 spores/m3).
Unlike results for asthma symptoms, posi-
tive SPT fungal concentrations were not
significantly associated with inhaler use
amongpediatric subjects (p<0.37).
Total pollen, Adenostomapollen, person-
al 03, and stationary site outdoor 03 were
not associated with as-needed -agonist
inhaler use. No interaction or confounding
between these environmental variables and
fungal spores or weather variables was found
in relation to inhaler use. However, in con-
trast to the other outcomes, inhaler use was
associated with PM1O concentrations.
Controlling for average relative humidity,
inhaler puffs increased by 0.15/10 pg/m3 of
PM1O (p<0.02). No interaction or con-
founding between PM1O and fungal spores
was found.
Regression analysis ofindividualfungal
types. To assess the potential effects of the
different types of test and nontest fungi on
asthma status, regression models for each of
the three outcomes included the following
fungal types: 1) each the five separate SPT
fungi except Aspergillus and Penicillium,
which had to be combined as discussed
above; 2) total basidiospores; 3) the major
identified basidiospore, Coprinus, 4) total
ascospores; and 5) the major nontest spores
other than the basidiospores or ascospores
(the deuteromycetes Periconia and Botrytis,
hyphal fragments, rusts, and unidentified
taxa). Regressions for each of the five test
fungi involved subjects allergic to the spore
type, whereas regressions for the nontest fun-
gal types involved all 22 subjects (Table 7).
One extreme outlier for the basidiospores
due to gastromycete contamination discussed
above and two high ascospore oudiers >677
spores/m3 (>8 times the interquartile range)
were excluded from the regression analysis
because they had a great influence on para-
meter estimates and residual errors andled to
negative results for basidiospores and unex-
pected significant inverse associations for
ascospores. The same was found for one
Periconia outlier (402 spores/m3; >5 times
the interquartile range), which when includ-
ed in regressions, halved the regression para-
meter estimates.
Themagnitudes ofeffect on all three out-
comes by Alternaria and Helminthosporium
were notably greater than the other test
spores Cladosporium and Aspergillus-
Penicillium when estimates of effect were
Table7. Effects ofspecificfungaltypes onthree asthma outcomes, theAlpine Asthma Panel Study,9May-3July 19948
Asthma symptom scores Evening peak expiratoryflow As-neededli-agonist inhaler
Change/90th Change/90th Change/90th
Fungal types (90th Change/1,000 percentile- Change/1,O000 percentile- Cae/O0prcni-
percentile-minimum) particles/rn ± SE mininum ± SE particles/rn ±SE minimum ±SE patce/n E mnmm±S
Totalfungi (3,883spores/rn3) 0.09 ±0.03* 0.36 ±0.10* -3.10 ±1.35 ~ -12.06 ±5.23** 08±0.5.3±01*
(1,93sporesrn)0.19±0.0 0.36±014~ -8.186 3370 -12.18±7.30 0.23±. 0.10 DS±02
.........m. FSl t in 0 * I f Totalascospores(232spores/rn3)-0.03 ± 0.33 001 ± 008 2308 + 1648 535±3.82 -0.85±0.53 -0.20±0.12~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~1~........
.... Penconia (121 spores/rn3) 2,snf.33 i .5* 03 07* 50 98 64±33 .8 10 02
Hyphae(331fragments/rn3)0.84±0.32k - 028 ± o lot5390 + 1627* 1184±539* 1.25±0.56" 0.41±~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qq t f m
Unidentifieds-Pres( ll20spores/rn4):t 100.08 01206091 689074415 10617±4.850 0.80i ~ 03±.
SE standard error~~~~~~~~~~~~~~~~~~~~~~~~~~.. .II ''41 8A11models control for weather~~~~~~~~~~~~~~~~~~~~~~~~t- -. %: ~ s fL s bRegessonsnclded llegic ubjcts nly(Altrnaia, 6 sbjecs Cadosorim 10subectsHelinthspoium,11 ubjets;Aspegils-Peicilium 11sub jets1 ubecalegi t al fng; nd1 ubec nl alegi t Atenaiadi nt seasnede ) aois ihaer);reaiin mdes ncud al 2 ubecs
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expressed per 1,000 spores/m3 (Table 7).
However, differences were small when esti-
mates of effect were expressed for 90th per-
centile increases in spore concentrations.
None of the models were significant for
Aspergillus-Penicillium and only borderline
significant effects were found for the remain-
ing test fungi in relation to PEFR (p<0.1).
Effects ofAlternariawere significant only for
symptoms, although the direction and mag-
nitude ofparameter estimates for PEFR and
inhaler useweresuggestiveofadverseeffects.
Asthma symptom scores among all 22
subjects were strongly associated with
basidiospore levels (symptom scores
increased 1.5/1,000 spores/m3; p<0.00005,
controlling for temperature). The magni-
tude ofthis effect was the same for a regres-
sion involving only the 16 subjects with
positive skin tests for fungi (model not
shown). Asthma symptom scores were also
strongly associated with basidiospore levels
on the day prior to the dayofasthma symp-
tom reporting, suggesting a possible lag
effect as well (symptom scores increased
1.0/1,000 spores/m3; p<0.004, controlling
for temperature; model not shown).
However, neither PEFR nor as-needed 3-
agonist inhaler use were associated with
basidiospore levels. The magnitude of the
basidiospore effect was not larger than
many of the other fungal types when esti-
mates ofeffect were expressed as a 90th per-
centile effect, similar to what was found for
Alternariaand Helminthosporium. The slope
ofeffect was larger still for the basidiospore
genus Coprinus (symptom scores increased
2.3 vs. 1.5/1,000 spores/m3, respectively),
whereas the 90th percentile effect was simi-
lar again. None of the outcome variables
were associated with ascospore concentra-
tions. Notably large slopes were found for
the other nontest fungal types, including
the deuteromycetes Periconia and Botrytis,
hyphal fragments, rusts, and unidentified
taxa. Again, 90th percentile effects were not
much different than other fungal types,
with the possible exception ofhyphal frag-
ments and PEFR (-18 1/min decrease for
331 fragments/m3). Interestingly, the most
consistently significant effects across all out-
comes were from the hyphal fragments.
Given that there was a decreasing linear
trend in asthma symptoms andbasidiospores,
it is possible that the association found was
due to temporal confounding. Therefore, the
analysis was split into two time periods: an
earlier period ofcool, damp weather prior to
27 May, having higher basidiospore concen-
trations and symptom scores, and alater peri-
od of warm, dry weather, having lower
basidiospore concentrations and symptom
scores. The early period showed an effect of
basidiospore on asthma symptoms, which
was somewhat smaller than the analysis for
the total period (symptom scores increased
1.0/1,000 spores/m3; p<0.02, controlling for
temperature). There was no significant effect
for the later time period. This indicates that
the effect ofbasidiospores was largely isolated
to the first 3 weeks when levels ofsporulation
were higher. However, the effect of total
spore concentrations on asthma symptoms
was statistically significant (p<0.02) for both
time periods (symptom scores increased 0.12
and 0.09 /1,000 spores/m3 for the earlier and
laterperiod, respectively).
Individual regression analysis.
Autoregressions for 7 of 13 pediatric asth-
matics showed statistically significant and
large changes in asthma symptom scores
from basidiospores (2.5-6.0/1,000
basidiospores/m3), but none ofthe 9 adults
showed significant autoregressions (Table
8). The autoregressions showed far fewer
significant effects from the test spores for
either symptom scores, PEFR, or inhaler
use. One male adult subject not allergic to
test spores (subject 14) showed unexpected
inverse associations between symptoms and
test spores (p<O.1) and between inhaler use
and test spores (p<0.05). Two pediatric
subjects who were not allergic to test spores
(subjects 3 and 8) and one adult nonaller-
gic subject (subject 17) showed significant
or borderline significant effects from test
fungi on one or two ofthe three outcomes.
This suggests that either the SPTs were
falsely negative or other nontest fungi were
driving the associations. The two pediatric
subjects in question showed marked effects
on symptoms scores from basidiospores
(symptom scores increased 6.0 and 3.9
/1,000 basidiospores/m3). Coregression of
test spores with basidiospores in autoregres-
sion models for these two subjects showed
that for pediatric subject 3 the regression
parameter for symptoms and test spores
was markedly reduced (0.19/1,000
spores/m3; p<0.3) and the significant effect
of basidiospores was relatively unchanged.
For the other subjects in question, core-
gression did not alter effects of either test
spores or basidiospores.
Other individual autoregressions tested
the relationship of the three outcomes to
Alternaria, the nontest fungi variable, and
the positive SPT fungi variable (results not
shown). Autoregressions for pediatric sub-
jects 6 and 11 and adult subjects 19 and 22
showed significant adverse effects on one to
two outcomes in association with Alternaria
and/or positive SPT fungi. Autoregressions
for pediatric subjects 4 and 8 and adult sub-
Table& Results ofautoregressive modelsfor individual subjects: relationship ofasthma outcomesto selected
fungal exposures at1,000spores/m3 ofaira
Change in peak Change in
Change in symptom expiratory as-needed
Change in symptom score from flow rate from inhaler use from
score from total deuteromycete deuteromycete deuteromycete
Subject basidiospores ± SE test spores ± SEb test spores ± SE test spores ± SE
Pediatric subjects
1 -1.73 ±0.93* -0.15 ± 0.11 9.34 ± 6.34
2 1.31 ± 1.70 0.22 ± 0.19 -1.84 ± 4.90 0.17 ±0.18
3 5.99 ± 1.50? 0.35 ± 0.20 - -0.16 ± 0.23
4 1.66±2.40 0.39±0.27 -5.14±5.45 0.19±0.23
5 4.57 ± 1.50? 0.32 ± 0.17* -3.32 ± 4.51 1.01 ± 0.58
6 5.98 ± 1.40? 0.36 ± 0.16** -30.51 ± 18.66 0.00 ± 0.06
7 -3.45 ± 2.20 -0.18 ± 0.27 -1.14 ± 9.20 -0.34 ± 0.58
8 3.90 ± 1.15? 0.38 ±0.13? 0.54 ± 5.46 0.29 ± 0.15*
9 2.88 ± 1.80 0.25 ± 0.20 0.62 ± 5.45 0.80 ± 0.60
10 2.72 ± 1.20* 0.10 ± 0.16 -2.93 ± 10.00 0.36 ± 0.22
11 3.17± 1.08t 0.17 ± 0.13 -8.72 ± 9.12 0.00± 0.08
12 0.33 ± 0.75 -0.02 ± 0.08 -4.41 ± 3.46 0.02 ± 0.27
13 2.52 ± 1.20** 0.36 ± 0.14** 1.52 ± 4.35 0.27 ± 0.50
Adultsubjects
14 -0.97 ± 1.90 -0.41 ± 0.20 4.98 ± 11.00 -0.45 ± 0.20*
15 1.61 ± 1.60 -0.09 ± 0.18 3.19± 9.11 -0.36 ± 0.47
16 0.95 ± 1.50 0.04 ± 0.17 -1.45 ± 15.88 0.51 ±0.63
17 0.32 ± 1.80 0.08 ± 0.20 -7.06 ± 3.26** -0.14 ± 0.30
18 1.64 ± 1.90 0.37 ± 0.20* -0.77 ± 3.68
19 2.08 ± 1.18* 0.40 ±0.12t -3.33 ± 12.00 0.47 ± 0.28
20 -0.60 ± 0.77 0.07 ± 0.08 -2.39 ± 11.00 -0.09 ± 0.35
21 -0.09±1.10 0.03±0.13 5.94±16.00 0.43±0.32
22 1.17±3.70 0.42±0.22* -5.79±7.42 0.34±0.15**
SE, standard error.
aRegression models control forweather and first order autocorrelation.
bFungal spore concentrations of those five genera represented by the allergy skin prick tests, namely,
Altemaria, Helminthosporium, Cladosporium, Aspergillus, and Penicillium.
*p<0.1;**p<0.05;tp<0.01; tp<0.001.
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jects 19 and 22 showed significant adverse
effects on one to two outcomes in associa-
tion with nontest fungi (ofthese, only sub-
ject 8 showed significant effects from
basidiospores). For the remaining subjects,
the direction ofeffects was in the expected
direction for most models (positive for
symptoms and inhaler use and negative for
PEFR; several p<O.1), thereby contributing
informative data to the population analysis.
Individual autoregressions for the relation-
ship of personal 03 to the three outcomes
showed only one significant adverse effect
on PEFR (decrease of 21.7 I/min/10 ppb,
adult subject 6), but two significant protec-
tive effects on PEFR (increase of 6.6
I/min/10 ppb, pediatric subject 4; 23.4
I/min/10 ppb, adult subject 19). There was
also one significant adverse effect in inhaler
use (0.33 puffs/10 ppb, pediatric subject
12).
Discussion
Overview. The present study showed that
outdoor fungal spore concentrations have an
adverse effect on dailyasthmaseverity, partic-
ularly in regard to reported asthma symptom
levels. This finding was supported byadverse
effects offungal spores on evening PEFR and
as-needed n-agonist inhaler use. The present
findings are particularly relevant to patients
with perennial asthma because subjects were
selected on the basis ofworsening asthma
during the warm season. The magnitude of
effect ofoutdoor fungi was marginally larger
when the analysis focused on subjects with
positive skin prick tests to five deuteromycete
fungi commonly assessed in allergy practices,
particularly when the explanatory variable
was concentrations of those fungal taxa to
which the subject had representative positive
SPTs. These fungi included Alternaria,
Clasoporium, Helminthosporium, Aspergillus,
and Penicillium genera. However, there was
evidence that other fungi may have an equal
orgreater effect on asthma severity, including
basidiospores (notably Coprinus), Periconia,
Botrytis, hyphal fragments, rusts, and uniden-
tified taxa. Most ofthese different groups of
fungi were not strongly correlated with each
other, however some, most notably the
deuteromycetes, hyphal fragments, and
unidentified spores, tended to be moderately
correlated (R = 0.5-0.7). Because the mea-
surement offungal exposures relied on a sin-
gle outdoorstationarysite, it isdifficult to say
which ofthe intercorrelated fungal types are
drivingthe associations.
The only significant effect from air pol-
lution was between as-needed inhaler use
and PM10. Despite an intense effort to col-
lect personal 03 data, no associations were
detected. Although it would not have oth-
erwise been unexpected for such low 03
levels (Table 2), this contrasts with our ear-
lier findings in a more urbanized area of
San Diego county where similar personal
03 concentrations were measured. Some of
the possible reasons for this contrast are
discussed below.
Effects offungi. This is the second in a
series of asthma panel studies by the pre-
sent group of investigators, who are using
longitudinal data analysis to examine the
relationship between daily asthma status
and outdoor fungal concentrations.
Although the first study was conducted in a
climatologically different region (coastal vs.
inland San Diego county) and season (fall
vs. late spring), results were consistent with
the present findings regarding the effect of
total fungal spore concentrations on symp-
tom scores and on inhaler use (11).
However, in the previous study, a greater
magnitude of response for positive SPT
fungal concentrations in comparison to
total fungi was found only for inhaler use
and not for asthma symptom score. Similar
effect levels were found for the two studies
for both asthma symptoms and inhaler use
in relation to concentrations of fungi,
which were not included in the SPT bat-
tery (same five fungal taxa used). This was
exemplified by the effect of basidiospores
on asthma symptoms among the 12 pedi-
atric subjects in the previous study (symp-
tom scores increased by 1.2/1,000 fungal
spores/m3; p<O.07). Sample size, cohort,
geographical, or seasonal factors may
explain the few differences in results
between the two studies, suggesting the
need for additional longitudinal studies in
more climatologically diverse areas in order
to generalize the present findings to other
populations ofsusceptible asthmatics.
Few other cohort studies have been
directed at determining the importance of
fungi to daily asthma severity, and results
from those studies are limited. Klabuschnigg
and colleagues (3) examined data collected
daily from 40 asthmatics over a 6-weekperi-
od in an Austrian summer camp. The
authors graphically showed a relationship of
asthmatic complaints to pollen and to
Cladosporium concentrations; however, no
statistical analyses were presented. Another
study in the Netherlands involved measure-
ments of colony-forming units of fungal
spores outside ofthe homes ofeight fungal
allergic asthmatics; measurements were
taken approximately once per month rather
than on sequential days (4). This study
showed significantly lower average PEFR on
days when fungal spore concentrations were
highest versus the lowest days (mean PEFR
354 vs. 4001/min, respectively;p<O.05).
Manyfungal spores are capable ofreach-
ing the conducting airways ofthe lungs, and
some have been found to produce inflam-
matory effects on the respiratory mucosa of
allergic asthmatics, as demonstrated in bron-
choalveolar lavage studies (26). Indirect evi-
dence of allergic IgE-mediated responses to
fungi was provided by Licorish et al. (27)
who performed bronchial challenges on
seven young adults with mild asthma using
either Alternaria or Penicillium spores,
depending upon the patient's allergy
(approximately 2,000 and 10,000 spores/mi3,
respectively). Pulmonary function tests and
clinical symptoms were consistent with both
immediate and late onset asthmatic respons-
es. Compared to other allergens, the relative
importance offungal spores with respect to
IgE-mediated responses among allergic asth-
matics is not known. Results ofseveral suc-
cessful experimental trials of mold
immunotherapy suggests that fungal anti-
gens are clinically important (22). The
threshold concentration for inducing an
asthmatic response by any fungal species is
also unknown, but it is likely to vary based
upon individual sensitivity and fungal
species (22). The present study supports this
view because results showed greater magni-
tudes of response when the fungal-specific
allergies ofthe individual were accounted for
and the magnitude ofresponse per concen-
tration ofspores varied depending upon the
spore type (e.g., basidiomycetes). The possi-
bility that fungal allergens may have more
potent effects in susceptible individuals
compared to other allergens is supported by
a study which examined 11 asthmatics seen
at the Mayo clinic who had one or more
episodes ofrespiratory arrestduring the peri-
od 1980-1989 (5). Ten ofthese asthmatics
were both skin test positive for Alternaria
and had their respiratory arrest during the
Alternaria aeroallergen season of summer
and early fall. Consistent with this is data
from an ecological study conducted in
Chicago, Illinois, during the period May to
October from 1985 to 1989 that showed
the odds ofdeath from asthma for 67 asth-
matic patients ages 5-34 years were twofold
higher on days when fungal spore concen-
trations were at or above 1,000 spores/m3
versus days below 1,000 spores/m3 (95%
CI, 1.31-3.56) (28).
The effect estimates for the population
sample in the present study were in most
cases relatively small, given the range of
fungal spore concentrations measured
(655-6,110 spores/m3). This was particu-
larly evident for PEFR deficits, which were
in most cases not more notable than -10
1/min for a 90th percentile increase in any
of the fungal types (Table 7). This change
itselfis unlikely to have any dinical signifi-
cance for an individual asthmatic. However,
given such small physiologic changes in this
Environmental Health Perspectives * Volume 105, Number6, June 1997 631Articles - Delfino et al.
cohort of22 asthmatics, more adverse out-
comes resulting from fungal exposures, such
as ER visits or hospital admissions, could
occur among the larger population ofasth-
matics (29). A cautionary note is appropri-
ate here; nonexperimental studies, such as
the present epidemiologic investigation, are
generally viewed by epidemiologists to yield
estimates of effect applicable to popula-
tions, not individuals. There are two rea-
sons for estimating effects at a population
level in epidemiologic research: 1) although
the main interest is in the clinical well-
being ofthe individual, the ultimate goal of
epidemiologic research is to improve the
health status ofpopulations; and 2) a popu-
lation is required in research, which aims to
make causal inferences about relationships
between certain factors and disease, particu-
larly when inferences must be externally
valid for the target group of interest (e.g.,
asthmatics) (30).
Despite the small population estimates
ofeffect reported here for most ofthe fun-
gal variables, it is possible that some indi-
viduals are more sensitive than others and
that clinically important asthma flares from
fungal exposures could be seen in other
geographical areas having higher levels of
outdoor fungi. The first issue is demon-
strated with the individual autoregressions,
which showed that four individuals (sub-
jects 6, 8, 13, and 19) had nearly a unit
increase in symptom score from a 90th per-
centile increase in test fungi concentration
(2,156 spores/m3, p<0.05; changes in
Table 8 are for 1,000 spores/m3). The sec-
ond issue is demonstrated by the slope of
the association between symptoms and
basidiospores, which if correct for the
extrapolations to 1,000 spores/m3 shown
in Tables 7 and 8, would represent a mod-
est to severe clinical impact on an individ-
ual asthmatic (increase in score of 1.5 to a
maximum of 5, which indicates a need for
medical evaluation). Concentrations
>1,000 basidiospores/m3 have been mea-
sured in areas with more frequent rain and
higher humidity during the warm seasons,
such as during the late spring and fall sea-
sons in Tulsa, Oklahoma (25). Other spore
types less well researched had similarly
large effects per 1,000 spores/m3, with
most regressions on all three outcomes
being statitically significant (Periconia,
Botrytis, and hyphal fragments). An analo-
gous situation was found for fungal taxa
commonly tested for in allergy assessments,
namely, Alternaria and Helminthosporium,
in which effects per 1,000 spores/m3 were
large and represent clinically adverse effects
on both asthma symptom severity and
PEFR for both fungal taxa and on inhaler
use for Helminthosporium (Table 7). As
with basidiospores, these magnitudes of
effect are extrapolations from the regression
slopes and are notably larger than the 90th
percentile effects. Again, if the slopes are
correct, the extrapolated effects could be
found in other areas, as exemplified by the
Mayo study of respiratory arrests among
asthmatics reported above in which mea-
sured concentrations of Alternaria were
.1,000 spores/m3 in southeastern
Minnesota on a majority ofdays fromJune
through October 1985 (5). An alternate
explanation for the present findings oflarg-
er slopes for some of these fungal types is
that effects for one fungal taxon could have
been confounded with that of another,
leading to an inflation or deflation of
effects over the same spore per cubic meter
change. This may explain in part why
effects per 1,000 spores/m3 for fungal taxa
with otherwise low concentrations are
much larger that the higher concentration
spores (e.g., Alternariavs. Cladosporium).
It is also possible that outdoor fungal
spore levels in the present study did not
fully capture the magnitude ofeffects from
personal respiratory exposure to fungal
spores, particularly since indoor fungi prob-
ably contribute substantially to personal
fungal exposure (31) and short-term peaks
in spores can be several magnitudes higher
than those observed (25). Misclassification
of true fungal exposure would likely have
biased the estimates ofeffect in the present
study toward the null hypothesis of no
effect. A positive bias could have occurred if
other allergens etiologically linked to asth-
ma, such as house dust particles carrying
various antigens, increased during times of
fungal sporulation due to shared meteoro-
logical determinants.
The relative differences in the present
findings between the effects of the nonskin
tested fungal types and the patient-specific
allergic fungi should be interpreted with cau-
tion. For instance, the positive association
between symptoms and basidiospores and
the effect by other nonskin test fungi sug-
gests that subjects were responding to other
fungal species not commonly tested for in
allergypractices. The mostnotable finding in
this regard was that in the individual autore-
gression analysis, 7 of13 pediatric asthmatics
showed statistically significant and large
changes in asthma symptom scores in rela-
tion to basidiospores (Table 8). The
basidiospores are not typically included as
part ofan allergyworkup ofpotentially aller-
gic asthmatics in any region to our knowl-
edge outside ofresearch settings. Lehrer et al.
(32) clearly demonstrated theallergenicity of
basidiospores among asthmatics by finding
positive SPTs to basidiospores in 30% of
339 asthmatics, as compared with only 18%
of 343 subjects without asthma (p<0.005).
In one study, 8 asthmatics with both positive
skin test reactivity and positive radioaller-
gosorbent test to basidiospores showed apos-
itive bronchoprovocation challenge with
basidiospores, while 6 atopic asthmatics with
negative basidiospore tests had negative chal-
lenges; both groups had similar levels of
methacholine reactivity (33). Additional evi-
dence for the importance of the
basidiospores has been shown by increased
asthma hospital admission and emergency
room visit rates during outdoor peaks of
basidiospore concentrations (6,8,9). Another
issue ofconcern regarding the present study
is that although many ofthe fungal taxa not
represented in the SPT battery, such as the
basidiospores, could be microscopically iden-
tified in the present study, a large proportion
of the total spore concentration was com-
prised of unidentified taxa (mean 717
spores/m3), which were significantly associat-
ed with PEFR and inhaler use (Table 7).
Finally, allergy testing used in this study,
namely epicutaneous skin punctures, can
produce false negatives. Confirmatory intra-
dermal skin tests for negative epicutaneous
tests would improve sensitivity but can pro-
duce false positive results. It is possible that a
battery offungal allergy tests larger than that
used in the present study could still miss eti-
ologically important fungal allergens carried
byotherfungal taxa. This is consistentwith a
published finding that the association of
asthma to allergen skin test reactivity using
only 18 allergens (pollens, molds, and dust)
was notably weaker than the association
between serum IgEleveland asthma (1).
Effects ofair pollution andpollen.
There was almost no effect ofair pollution
on the asthma outcomes in the present
study. The effect ofPMIO on inhaler use
may have been spurious, given that both
symptoms and PEFR were unrelated to
PM O. The lack of associations for pollen
and PM1O were not unexpected given the
low levels of these agents (Table 2). One
possible source of negative bias is that
semivolatile components of particulate
matter <2.5 pm in aerodynamic diameter
(PM2 5) may be lost with tapered-element
oscillating microbalance samplers used to
measurePM1O (15). This does not preclude
important effects of particulate air pollu-
tion in different settings or pollen during
the peak pollen season for the study area of
March andApril (a topic ofcurrent investi-
gation). Adding back the 13 high outlier
observations for personal 03 did not alter
the above negative results. It is also possi-
ble, although not verifiable, that subjects
were not uncapping the sampler to a degree
sufficient to negatively bias estimates of
effect for ozone.
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Results from the previous asthma panel
study discussed above contrast the present
negative findings for 03 (11). The previous
study was conducted in an urban area of
San Diego county and showed positive
associations ofdaily asthma severity to per-
sonal 03 exposure levels that were some-
what lower than those in the present study
(11). For the 12 subjects followed over 6
weeks in that study, a 90th percentile
increase in personal 03 (25 ppb 12-hr aver-
age) led to a 25% increase in mean symp-
tom scores (95% CI, 0-49%) and to a
26% increase in mean inhaler use (95%
CI, 3-48%). The population for the pre-
sent study was a semirural community of
San Diego county located at the inversion
layer base, typically having relatively high
outdoor 03 and low particulate air pollu-
tion levels. Given this, it is possible that
joint exposure to modest elevations of 03
in combination with other air pollutants
common in urban environments may be
etiologically important to adverse respirato-
ry effects among asthmatics.
There is another factor that may have
contributed to differences in results: the
inland area of the present study generally
experiences daily maximum temperatures
that are 10-20°F higher than the coastal
communities of San Diego county repre-
sented by the former study. The use of air
conditioners is therefore considerably more
frequent in Alpine than in the coastal area,
as evidenced in the activity diaries of sub-
jects (12) and reports by the Alpine school
teachers of the pediatric subjects. None of
the subjects in the previous study used air
conditioning in their homes, as compared
to 86% in theAlpine study. We also found
no effects of temperature in the previous
study, but in the present study, we found
unusually strong protective effects ofhigh-
er temperature on symptoms, PEFR, and
as-needed inhaler use. Rather than a direct
protective effect of temperature, it is more
likely that higher temperatures were dri-
ving a decrease in personal allergen expo-
sure due to filtration of indoor allergen
particles (including particles carrying dust
mite antigens) from refrigerative air-condi-
tioning through precipitation in removed
water (34) and the inhibitory effects ofcool
dry air on indoor fungal growth and sporu-
lation (35). Short-term temporal changes
in indoor airborne particulates related to
the onset of hot, dry weather could also
occur as a result ofchanges in air exchange
rates, physical disturbance from increased
indoor residence time, and changes in the
aerodynamic properties of particles.
Although cool, dry air resulting from
refrigerative air-conditioning is expected to
inhibit indoor dust mite growth (36), this
would likely occur over longer seasonal
time periods. For instance, the warm, dry
period after 26 May in the present study
would be expected to gradually diminish
indoor dust mite numbers over the remain-
der of the study. Antigenic particles from
dust mites, on the other hand, could still
persist in household reservoirs such as car-
peting and furniture. However, the litera-
ture on day-to-day changes in airborne
dust mite antigen exposure is incomplete,
and we are not aware of any published
research that has examined the relationship
of asthma severity to daily personal expo-
sure to airborne allergens. The approach to
measuring personal dust mite antigen
exposures has been recently presented in
the literature, although the methods are
not well defined (37).
Because 03 is maximally generated by
sunlight and is strongly and positively cor-
related to temperature, the indirectly pro-
tective effect of hot dry weather on aller-
gen-induced asthma could have over-
whelmed any ofthe suspected effects of03
on airway caliber or inflammation among
asthmatics (38). Such an effect should be
kept in mind in studies examining the
effect ofair pollutants on asthma morbidi-
ty, particularly when meteorological factors
are used as control variables. Also, small
but significant intercorrelations between
aeroallergens and air pollutants were found
in the present study (Table 3), which pro-
vides evidence that outdoor allergens
should not be ignored in studies ofasthma
and outdoor air pollution. Compared to
the southwestern United States, epidemio-
logical research findings in areas of the
United States where heat and humidity
often increase together are likely to be dif-
ferent, particularly since fungal spore and
dust mite levels would be more likely to be
positively correlated to temporal trends in
photochemical air pollutants.
Strengths and limitations. Exposure
misclassification is a major limitation of
environmental epidemiologic research clear-
ly applicable to the present study. For
instance, we do not know the degree to
which the outdoor fungal concentrations
we measured represented personal expo-
sures. However, personal sampling technol-
ogy for fungal spores does not exist and is
not an active area ofresearch, to our knowl-
edge. It also is unclear how to weight out-
door exposure to fungi by the number of
hours spent outdoors, given their diverse
particle size distributions and expectation of
variable degrees of penetration into indoor
environments, which may also have signifi-
cant indoor point sources (e.g., damp sub-
floors). One limitation of the present
research that prohibited such modeling was
alackofindoor air samples. We believe that
it is important for future epidemiologic
research on the respiratory effects of air-
borne fungi to develop approaches to model
personal exposure to specific fungal taxa. A
currently feasible approach would be to
examine indoor and outdoor microenviron-
mental concentrations for each subject. A
further advancement would be to estimate
internal thoracic dose based upon minute
ventilation from activity diaries and particle
size distributions ofthe fungal taxa.
Outcome misclassification in diary
studies is an additional source of error due
to a lack of truly verifiable patient data.
This can occur through a lack of subject
compliance (invalid PEFR maneuvers, falsi-
fied records, and distant recall), an issue
that has plagued asthma diary studies to the
present (39,40). Data quality could be
greatly improved by the use ofsubnotebook
diaries, nebulizer chronologs, and forced
expiratory volume in 1 sec (FEV1)/PEFR
monitors that are electronic and time-date
stamped, but these alternatives are costly.
The alternative to the above-mentioned
approaches of personal exposure measure-
ments and verifiable response data that is
often used in epidemiologic studies is to
enhance statistical power by increasing
sample size, which can overwhelm method-
ological inaccuracy and interindividual
variability. However, a considerable
amount ofbiological information is lost in
the bargain. Although much ofthis mecha-
nistic information can be provided by
experimental studies, it is difficult to
extrapolate the experimental conditions to
conditions in natural settings. The present
repeated-measures design actually enhances
power because the sample size was not sim-
ply 22 subjects, but was the person-days of
observation, which for symptom scores and
fungi was 1,100.
The repeated measurements in each sub-
ject allowed analyses to be performed on
each individual. The present panel design
shares similar features to the cross-over dini-
cal trial in that both study designs are statis-
tically efficient (enhanced signal-to-noise
ratio) because multiple treatment conditions
(or exposures) are studied in each subject
and variability in exposure-response rela-
tionships due to between-subject character-
istics is controlled for by design (41). The
last advantage is due to a reduction in the
variability of the response variable without
reductions in the magnitude of the expo-
sure-response relationship, thereby enhanc-
ing power and precision (42). Nevertheless,
intra-individual temporal variation due to
measurement error is a major limitation.
Although many subjects showed statistically
significant effects from fungi, particularly for
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symptoms among the pediatric subjects and
basidiospores, it is probably not justified at
this point to call them responders and the
others nonresponders. Presenting dose-
response information on each individual is
an important task for an experimental study
or clinical trial. However, this is a nonexper-
imental epidemiologic study, which has lim-
ited power to examine effects in individual
subjects. The primary limitation relates to
the fundamental difference between experi-
mental versus nonexperimental epidemio-
logic (observational) studies: the investigator
in a nonexperimental study does not have
control over the conditions of exposure,
induding reduction in thevariation ofextra-
neous factors in comparison with the factor
ofinterest (43). One major consequence of
this is the difficulty ofaccurately assessing
the conditions of exposure, which leads to
exposure misclassification and inflation of
random error. This in turn diminishes the
statistical power to detect an effect. In the
present study there is, by the nature of its
design, insufficient accuracy in the assess-
ment of the conditions of exposure to
declare that any individual regression analy-
sis is valid for the subject. Nevertheless, we
have presented individual autoregressions
and, while marginal or significant effects
(p<O.1 or p<0.05) are seen for certain indi-
viduals, this should not be interpreted as
more indicative of an adverse effect among
those particular individuals. The expected
lack of clear heterogeneity of effects from
individual regressions as compared with
population averaged effects was previously
shown in similar studies by Neas et al. (44)
who described a panel study ofdaily respira-
toryeffects ofairpollutants; Hoeketal. (45)
who used four repeated pulmonary function
tests in children; and a reanalysis of three
summer camp studies of air pollution and
pulmonary function (46). Brunekreef et al.
(46) provided evidence that thevariabilityof
individual regression slopes may be largely
due to within-subject variability rather than
between-subject variability. One general
solution to this issue is to advance the field
ofair pollution epidemiology by improving
methods ofrepeated measurement studies in
a manner that provides a view oftemporal
effects in individual subjects with a mini-
mum of exposure and outcome misclassifi-
cation. This paper, its companion paper by
Liu et al. (12) described above, and our pre-
vious asthma panel study (11), represent an
advancement in this direction because they
are among the first to use daily personal
ozone measurements overlongperiods.
Another issue that emerges from the
present results is that effects of fungal
spores were not entirely consistent across
the three asthma outcomes. Given the low
to modest intercorrelations between the
response variables reported above, it is
expected that exposures associated with one
outcome may not be associated with the
other outcomes. Differences in estimates of
effect across the outcomes are probably a
reflection of both the utility of multiple
asthma outcomes and how interindividual
variability contributes to such differences
in results. For instance, PEFR provides
information about physiological changes in
response to agents that may not be detected
with symptom reports, particularly since
some asthmatics appear to be poor per-
ceivers of bronchoconstriction (47). On
the other hand, the symptom scoring sys-
tem we use allows the asthmatic to gauge
his or her daily quality of life resulting
from asthma, whereas lung function mea-
surements such as PEFR represent a snap-
shot ofone physiological parameter, which
may not be representative of the daily
severity of asthma. This underestimate of
asthma severity by PEFR is particularly
likely ifthe patient has been using as-need-
ed 13-agonist inhalers throughout the day or
prior evening. The use ofinhalers, in turn,
is expected to vary between individuals
based upon their perception of asthma
severity and knowledge of, and compliance
with, appropriate inhaler use.
Implications. The findings from this
study suggest that elevations in outdoor
fungal spores may adversely affect symptom
severity, medication use, and lung function
ofasthmatics. This is the second in a series
oflongitudinal studies to showthat outdoor
levels of particular fungal spore types are
associated with dailyasthma status to differ-
ent degrees depending upon the genus-spe-
cific fungal allergy of the individual. The
effects of fungal spore concentrations were
generally greater among individuals having
skin prick sensitivity to common fungal
spore allergens. However, many exceptions
were found that suggested a more complex
and diverse pattern offungal allergy among
asthmatics. Ifskin prick allergy testing was
expanded to a wider variety offungal taxa,
these simple and well-tolerated tests could
be used to stratify large numbers ofindivid-
uals in epidemiological studies in order to
examine the effect of relevant aeroallergen
levels and their interactive influence with
other cofactors such as air pollutants. The
present findings suggest that further longi-
tudinal investigations of asthma determi-
nants are warranted involving both allergy
testing and aerometric measurements for a
wide range of fungi, pollen, and indoor
allergens. Advancements in the methods of
exposure assessment for airborne allergens is
urgendly needed for such investigations to
be carried out. Available tools and method-
ologies from air pollution research can and
should nowbe applied to this task.
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